课题基金 / 基金详情

EFFECT OF ADENOVIRUS E3 IMMUNOREGULATORY PROTEIN ON ALLOGENIC TRANSPLANTATION

EFFECT OF ADENOVIRUS E3 IMMUNOREGULATORY PROTEIN ON ALLOGENIC TRANSPLANTATION
腺病毒E3免疫调节蛋白对异体移植的影响
批准号:
6564319
负责人:
MARSHALL S. HORWITZ
金额:
$18.0万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-12-01 至 2003-11-30

项目摘要

项目成果

MARSHALL S. HORWITZ的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Human adenoviruses (Ads) encode a number of proteins that modulate the host responses against virus-infected cells. These proteins, whose genes are clustered in the early region 3 (E3) transcription unit, can (1) control transport of the class I major histocompatibility complex (MHC) heavy chain from the endoplasmic reticulum (ER) to the cell surface and (2) inhibit cytolysis induced by tumor necrosis factor alpha (TNFalpha). We postulated that the anti-class I MHC and anti-TNF effects of the Ad E3 genes may be used to facilitate allogenic pancreatic beta-cell transplantation and prevent autoimmune diabetes. Experiments have been performed in transgenic mice carrying the entire Ad2 E3 transcription region behind the rat insulin promoter (RIP) to test these hypothesis. Both tolerization to long-term allogeneic transplantation and prevention of lymphocytic choriomeningitis virus (LCMV)-induced autoimmune diabetes have been achieved in the presence of the Ad E3 transgenes expressed in islets. Encouraged by these initial results, we wish to extend these observations into new area of investigation by studying the contributions of individual Ad E3 gene products in the transplantation and LCMV models as well as introduce the Ad E3 immunoregulatory gene functions into the islets of nonobese diabetic (NOD) mice. The Ad E3 genes will also be inserted into a conditionally immortalized and growth controlled murine beta-cell line for the long term correction of diabetes by allogeneic transplantation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathogenesis of ELANE-Associated Neutropenia
  • 批准号:
    9011147
  • 项目类别:
  • 资助金额:
    $43.5万
  • 财政年份:
    2016
  • 负责人:
    MARSHALL S. HORWITZ
  • 依托单位:
Genomic Fate Maps
  • 批准号:
    7994875
  • 项目类别:
  • 资助金额:
    $10.0万
  • 财政年份:
    2010
  • 负责人:
    MARSHALL S. HORWITZ
  • 依托单位:
Genomic Fate Maps
  • 批准号:
    8215841
  • 项目类别:
  • 资助金额:
    $32.49万
  • 财政年份:
    2008
  • 负责人:
    MARSHALL S. HORWITZ
  • 依托单位:
Genomic Fate Maps
  • 批准号:
    8050657
  • 项目类别:
  • 资助金额:
    $32.49万
  • 财政年份:
    2008
  • 负责人:
    MARSHALL S. HORWITZ
  • 依托单位:
海外基金